Stock Events

Stock Events

Psyence Biomedical 

$0.011700
49
-$0.00-2.5%Friday 14:48
+$0.00+2.56%Friday 20:00After hours

Statistics

Day High
0.0121
Day Low
0.0117
52W High
0.0121
52W Low
0.0117
Volume
26,912
Avg. Volume
-
Mkt Cap
44,627.64
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-Profit Margin
Profitable
2023
2024
0Revenue
1.01MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PBMWW. It's not an investment recommendation.
Tesla
5
TSLA
NVIDIA
5
NVDA
Alphabet
4
GOOGL
Legal & General Group
4
LGEN.LSE

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Compass Pathways
CMPS
Mkt Cap1.6B
Compass Pathways operates in the psychedelic medicine sector, focusing on psilocybin therapy for depression, directly competing with Psyence's mental health treatment initiatives.
AtaiBeckley
ATAI
Mkt Cap2.73B
ATAI Life Sciences is a biotech company with a focus on psychedelic and non-psychedelic compounds for mental health disorders, overlapping with Psyence's focus areas.
GH Research
GHRS
Mkt Cap1.43B
GH Research PLC is involved in developing 5-MeO-DMT therapies for depression, a direct competitor in the psychedelic treatment space.
Nuveen Municipal Income
NUMI
Mkt Cap0
Numinus Wellness Inc. is engaged in psychedelic therapy research and development, including psilocybin and MDMA, competing in the same sector as Psyence.
Revive Therapeutics
RVVTF
Mkt Cap9.15M
Revive Therapeutics focuses on the research and development of therapeutics for medical needs and rare disorders, including psychedelic-based treatments.
TripAdvisor
TRIP
Mkt Cap1.08B
Red Light Holland Corp. is involved in the production, growth, and sale of a premium brand of magic truffles, competing in the natural psychedelics space.
Noveris Health Sciences
MYCOF
Mkt Cap42.74M
Mydecine Innovations Group is a biotech company focusing on developing and commercializing psychedelic medicines, including for mental health and addiction.

About

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.
Show More
CEO
Jody Aufrichtig
Employees
12
Country
Canada
ISIN
CA74449F1181

Listings

BOATS
BOATS
PBM.BOATS
XNAS
US
PBMWW
XNAS
US
PBM

0 Comments

Share your thoughts

FAQs

What is Psyence Biomedical stock price today?▼
The current price of PBMWW is $0.01 USD — it has decreased by -2.5% in the past 24 hours. Watch Psyence Biomedical stock price performance more closely on the chart.
What is Psyence Biomedical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Psyence Biomedical stocks are traded under the ticker PBMWW.
What is Psyence Biomedical market cap?▼
Today Psyence Biomedical has the market capitalization of 44,627.64
What is Psyence Biomedical revenue for the last year?▼
Psyence Biomedical revenue for the last year amounts to 0 USD.
What is Psyence Biomedical net income for the last year?▼
PBMWW net income for the last year is 1.01M USD.
How many employees does Psyence Biomedical have?▼
As of November 2, 2026, the company has 12 employees.
In which sector is Psyence Biomedical located?▼
Psyence Biomedical operates in the Health & Wellness sector.
When did Psyence Biomedical complete a stock split?▼
The last stock split for Psyence Biomedical was on February 2, 2026 with a ratio of 1:6.25.
Where is Psyence Biomedical headquartered?▼
Psyence Biomedical is headquartered in Toronto, Canada.